Iosimide

Iosimide

SCHEMBL898150

O=C(c1c(I)c(C(=O)N(CCO)CCO)c(I)c(C(=O)N(CCO)CCO)c1I)N(CCO)CCO

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA9 Q16790 1/20 0.33
POLB P06746 1/20 0.32
NTRK2 Q16620 1/20 0.31
ALPL P05186 1/20 0.30
TP53 P04637 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iosimide SCHEMBL8845588 1.00 CA2 (0.33) CA2CA12CA1CA9POLB
SCHEMBL11372360 0.89 CA2 (0.32) CA2
SCHEMBL4345180 0.87
SCHEMBL622232 0.85 CA2 (0.35) CA2POLBNTRK2ALPL
SCHEMBL9787642 0.84
SCHEMBL11372343 0.83
SCHEMBL621840 0.82 LMNA (0.49)
SCHEMBL9009268 0.80 LMNA (0.36) CA2CA1
SCHEMBL9734825 0.79
SCHEMBL9787637 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 599 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11903835-B2 Demineralized bone fiber composition for use in minimally invasive surgery THERACELL, LLC (US) 2024-02-20 US claimed
US-10994998-B2 Setting of hardenable bone substitute BONE SUPPORT AB (SE) 2021-05-04 US claimed
US-20200188122-A1 DEMINERALIZED BONE FIBER COMPOSITION FOR USE IN MINIMALLY INVASIVE SURGERY ARTERIOCYTE MEDICAL SYSTEMS, INC. 2020-06-18 US claimed
EP-3274003-B1 BIPHASIC CERAMIC BONE SUBSTITUTE BONE SUPPORT AB (SE) 2019-07-17 EP claimed
WO-2019048697-A1 MACRO- AND MICROPOROUS COMPOSITE CRYOGEL BIOMATERIAL FOR USE IN BONE REGENERATION BONE SUPPORT AB (SE) 2019-03-14 WO claimed
US-20180257939-A1 SETTING OF HARDENABLE BONE SUBSTITUTE BONE SUPPORT AB (SE) 2018-09-13 US claimed
EP-2185272-B1 REMOVAL OF SILICA FROM WATER SOLUBLE COMPOUNDS BY NANOFILTRATION AND REVERSE PHASE CHROMATOGRAPHY LIEBEL FLARSHEIM CO LLC (US) 2018-05-02 EP claimed
CN-105120908-B The improved solidification of hardenable bone substitute 骨支撑股份公司 2018-04-27 CN claimed
EP-2958603-B1 IMPROVED SETTING OF HARDENABLE BONE SUBSTITUTE BONE SUPPORT AB (SE) 2018-03-28 EP claimed
US-20180055969-A1 BIPHASIC CERAMIC BONE SUBSTITUTE BONE SUPPORT AB (SE) 2018-03-01 US claimed
CN-1100329-A Aqueous injectable formulations useful for radio-diagnosis comprising iodinated aromatic compounds used as X-ray contrast media BRACCO SPA (IT) 1995-03-22 CN claimed
WO-1994027644-A1 IODINATED PARAMAGNETIC CHELATES, AND THEIR USE AS CONTRAST AGENTS BRACCO S.P.A. (IT) 1994-12-08 WO claimed
WO-1994014478-A1 AQUEOUS INJECTABLE FORMULATIONS USEFUL FOR RADIO-DIAGNOSIS COMPRISING IODINATED AROMATIC COMPOUNDS USED AS X-RAY CONTRAST MEDIA BRACCO S.P.A. (IT) 1994-07-07 WO claimed
EP-0414288-B1 Contrast media NYCOMED IMAGING AS (NO) 1994-03-23 EP claimed
US-5242683-A Gastrointestinal tract, side effect reduction NYCOMED IMAGING AS (NO) 1993-09-07 US claimed
US-5204005-A Decolorization, separation, purification of water-soluble nonionic contrast media compounds; removing nonionic impurities MALLINCKRODT, INC. (US) 1993-04-20 US claimed
EP-0473729-A1 CONTRAST MEDIA NYCOMED AS (NO) 1992-03-11 EP claimed
WO-1991012868-A1 REVERSED PHASE CHROMATOGRAPHIC PROCESS MALLINCKRODT, INC. (US) 1991-09-05 WO claimed
EP-0414288-A1 Contrast media NYCOMED IMAGING AS (NO) 1991-02-27 EP claimed
WO-1991001149-A1 CONTRAST MEDIA NYCOMED AS (NO) 1991-02-07 WO claimed